• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

钙视网膜蛋白在先天性巨结肠疑似病例中的诊断作用

Diagnostic Role of Calretinin in Suspicious Cases of Hirschsprung's Disease.

作者信息

Singh Sanjeev K, Gupta Umesh K, Aggarwal Roopak, Rahman Rafey A, Gupta Nand K, Verma Vandana

机构信息

Pathology, Uttar Pradesh University of Medical Sciences, Saifai, Etawah, IND.

Pediatric Surgery, Uttar Pradesh University of Medical Sciences, Saifai, Etawah, IND.

出版信息

Cureus. 2021 Feb 16;13(2):e13373. doi: 10.7759/cureus.13373.

DOI:10.7759/cureus.13373
PMID:33754098
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7971728/
Abstract

Background Hirschsprung's disease (HD) is a developmental disorder of the intrinsic component of the enteric nervous system. It is characterized by the absence of ganglion cells in the myenteric and submucosal plexus. Histopathological diagnosis becomes difficult many times due to submucosal ganglionic cells are not easily identifiable. Aims and objective The aim of this study was to examine the clinical and histopathological features of HD and to establish the utility of calretinin staining to diagnose the case of suspicious HD. Materials and methods After taking necessary informed consent, we studied 41 cases in which clinical suspicion of HD had been made, in a study duration of three years (July 2017-June 2020). Open biopsies were taken from spastic segment, transition zone and dilated segment. Histopathological diagnosis had been made in three categories: HD, no Hirschsprung's disease (NHD) and suspicion of HD. Post histopathological diagnosis calretinin immunohistochemistry (IHC) was applied to all cases and interpretations were noted. Results On the basis of histopathological findings, 25 cases were diagnosed as HD, nine cases were marked for suspicion for HD and seven cases as NHD. After evaluating calretinin IHC on the suspicious case, total of 30 cases were confirmed as HD while the remaining 11 cases were confirmed as NHD. Twenty-four patients of HD were males while the remaining six cases were females. The age of patients ranged from four days to 10 years. Median age six days while 22 patients were in the neonatal period. Conclusion Calretinin immunostaining is a useful modality in diagnosing suspicious cases of HD. Its results are easy to interpret by less experienced pathologist with accuracy.

摘要

背景 先天性巨结肠症(HD)是一种肠神经系统内在组成部分的发育障碍性疾病。其特征是肌间神经丛和黏膜下神经丛中缺乏神经节细胞。由于黏膜下神经节细胞不易识别,组织病理学诊断多次变得困难。

目的 本研究的目的是检查HD的临床和组织病理学特征,并确定钙视网膜蛋白染色在诊断可疑HD病例中的效用。

材料和方法 在获得必要的知情同意后,我们在三年(2017年7月至2020年6月)的研究期间研究了41例临床怀疑为HD的病例。从痉挛段、过渡区和扩张段进行开放性活检。组织病理学诊断分为三类:HD、非先天性巨结肠症(NHD)和可疑HD。组织病理学诊断后,对所有病例进行钙视网膜蛋白免疫组织化学(IHC)检测并记录结果。

结果 根据组织病理学结果,25例被诊断为HD,9例被标记为可疑HD,7例为NHD。对可疑病例进行钙视网膜蛋白IHC评估后,共有30例被确诊为HD,其余11例被确诊为NHD。HD患者中24例为男性,其余6例为女性。患者年龄从4天到10岁不等。中位年龄为6天,22例患者处于新生儿期。

结论 钙视网膜蛋白免疫染色是诊断可疑HD病例的一种有用方法。其结果易于经验不足的病理学家准确解读。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed3c/7971728/59e1ea339a6a/cureus-0013-00000013373-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed3c/7971728/75a80f0d021f/cureus-0013-00000013373-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed3c/7971728/59e1ea339a6a/cureus-0013-00000013373-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed3c/7971728/75a80f0d021f/cureus-0013-00000013373-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed3c/7971728/59e1ea339a6a/cureus-0013-00000013373-i02.jpg

相似文献

1
Diagnostic Role of Calretinin in Suspicious Cases of Hirschsprung's Disease.钙视网膜蛋白在先天性巨结肠疑似病例中的诊断作用
Cureus. 2021 Feb 16;13(2):e13373. doi: 10.7759/cureus.13373.
2
Calretinin immunohistochemistry: A new cost-effective and easy method for diagnosis of Hirschsprung's disease.钙视网膜蛋白免疫组织化学:一种用于诊断先天性巨结肠的新的经济高效且简便的方法。
J Indian Assoc Pediatr Surg. 2013 Apr;18(2):66-8. doi: 10.4103/0971-9261.109355.
3
Clinical Relevance of Pathological Diagnosis of Hirschsprung's Disease with Acetylcholine-Esterase Histochemistry or Calretinin Immunohistochemistry.乙酰胆碱酯酶组织化学或钙视网膜蛋白免疫组织化学在先天性巨结肠病病理诊断中的临床意义
Children (Basel). 2024 Apr 3;11(4):428. doi: 10.3390/children11040428.
4
Evaluation of Calretinin as a New Marker in the Diagnosis of Hirschsprung Disease.评估钙视网膜蛋白作为先天性巨结肠症诊断新标志物的作用。
Iran J Pediatr. 2015 Apr;25(2):e367. doi: 10.5812/ijp.367. Epub 2015 Apr 18.
5
Calretinin and microtubule-associated protein-2 (MAP-2) immunohistochemistry in the diagnosis of Hirschsprung's disease.钙结合蛋白和微管相关蛋白-2(MAP-2)免疫组织化学在先天性巨结肠症诊断中的应用。
J Pediatr Surg. 2013 Oct;48(10):2112-7. doi: 10.1016/j.jpedsurg.2013.02.067.
6
Calretinin Immunohistochemistery: An Aid in the Diagnosis of Hirschsprung's Disease.钙视网膜蛋白免疫组织化学:先天性巨结肠病诊断的辅助手段。
Iran J Basic Med Sci. 2012 Sep;15(5):1053-9.
7
Hirschsprung's Disease in Neonates with Special Reference to Calretinin Immunohistochemistry.新生儿先天性巨结肠病——特别提及钙视网膜蛋白免疫组织化学
J Clin Diagn Res. 2015 Jul;9(7):EC06-9. doi: 10.7860/JCDR/2015/12470.6180. Epub 2015 Jul 1.
8
The loss of calretinin expression indicates aganglionosis in Hirschsprung's disease.钙视网膜蛋白表达缺失提示先天性巨结肠症中的无神经节细胞症。
J Clin Pathol. 2004 Jul;57(7):712-6. doi: 10.1136/jcp.2004.016030.
9
Immunohistochemistry-based comparative study in detection of Hirschsprung's disease in infants in a Tertiary Care Center.基于免疫组织化学的三级护理中心婴儿先天性巨结肠症检测的比较研究
J Lab Physicians. 2017 Apr-Jun;9(2):76-80. doi: 10.4103/0974-2727.199623.
10
Diagnostic roles of calretinin in hirschsprung disease: A comparison to neuron-specific enolase.钙结合蛋白在先天性巨结肠病中的诊断作用:与神经元特异性烯醇化酶的比较。
Saudi J Gastroenterol. 2017 Jan-Feb;23(1):60-66. doi: 10.4103/1319-3767.199118.

引用本文的文献

1
Developmental expression of calretinin in the mouse cochlea.钙结合蛋白家族成员 calretinin 在小鼠耳蜗中的发育性表达。
Eur J Histochem. 2024 Nov 6;68(4):4137. doi: 10.4081/ejh.2024.4137.
2
Clinical Relevance of Pathological Diagnosis of Hirschsprung's Disease with Acetylcholine-Esterase Histochemistry or Calretinin Immunohistochemistry.乙酰胆碱酯酶组织化学或钙视网膜蛋白免疫组织化学在先天性巨结肠病病理诊断中的临床意义
Children (Basel). 2024 Apr 3;11(4):428. doi: 10.3390/children11040428.

本文引用的文献

1
Hirschsprung's Disease in Neonates with Special Reference to Calretinin Immunohistochemistry.新生儿先天性巨结肠病——特别提及钙视网膜蛋白免疫组织化学
J Clin Diagn Res. 2015 Jul;9(7):EC06-9. doi: 10.7860/JCDR/2015/12470.6180. Epub 2015 Jul 1.
2
Hirschsprung's Disease in Newborns.新生儿先天性巨结肠症
J Neonatal Surg. 2013 Jan 1;2(4):51. eCollection 2013 Oct-Dec.
3
Evaluation of calretinin immunohistochemistry as an additional tool in confirming the diagnosis of Hirschsprung disease.评估钙视网膜蛋白免疫组织化学作为确诊先天性巨结肠症的辅助工具。
Pol J Pathol. 2014 Mar;65(1):34-9. doi: 10.5114/pjp.2014.42667.
4
Hirschsprung's disease in children: a five year experience at a university teaching hospital in northwestern Tanzania.儿童先天性巨结肠症:坦桑尼亚西北部一家大学教学医院的五年经验
BMC Res Notes. 2014 Jun 28;7:410. doi: 10.1186/1756-0500-7-410.
5
Hirschsprung disease and use of calretinin in inadequate rectal suction biopsies.先天性巨结肠病和钙视网膜蛋白在直肠吸引活检不足中的应用。
Arch Pathol Lab Med. 2013 Aug;137(8):1099-102. doi: 10.5858/arpa.2012-0220-OA.
6
Hirschsprung's disease.先天性巨结肠症
Semin Pediatr Surg. 2010 Aug;19(3):194-200. doi: 10.1053/j.sempedsurg.2010.03.004.
7
Calretinin immunohistochemistry: a simple and efficient tool to diagnose Hirschsprung disease.钙视网膜蛋白免疫组织化学:一种诊断先天性巨结肠病的简单有效工具。
Mod Pathol. 2009 Oct;22(10):1379-84. doi: 10.1038/modpathol.2009.110. Epub 2009 Jul 31.
8
Hirschsprung's disease, one of the most difficult diagnoses in pediatric surgery: a review of the problems from clinical practice to the bench.先天性巨结肠症,小儿外科最难诊断的病症之一:从临床实践到实验室研究的问题综述
Eur J Pediatr Surg. 2008 Jun;18(3):140-9. doi: 10.1055/s-2008-1038625.
9
Symptomatology, pathophysiology, diagnostic work-up, and treatment of Hirschsprung disease in infancy and childhood.婴幼儿及儿童期先天性巨结肠症的症状学、病理生理学、诊断检查及治疗
Curr Gastroenterol Rep. 2007 Jun;9(3):245-53. doi: 10.1007/s11894-007-0026-z.
10
Clinicopathological features in 102 cases of Hirschsprung disease.102例先天性巨结肠病的临床病理特征
Ann Saudi Med. 2006 May-Jun;26(3):200-4. doi: 10.5144/0256-4947.2006.200.